Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Menopausal Women With Early Breast Cancer”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT01050634
What this trial is testing

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Who this might be right for
Post Menopausal Women With Early Breast Cancer
Pfizer 980
Post-approval studies (Phase 4)Study completedNCT00323479
What this trial is testing

Arthralgia During Anastrozole Therapy for Breast Cancer

Who this might be right for
Early Breast Cancer
AstraZeneca 114
Not applicableLooking for participantsNCT04458532
What this trial is testing

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Memorial Sloan Kettering Cancer Center 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07394946
What this trial is testing

Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.

Who this might be right for
Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer
Cancer Care Hospital & Research Centre Foundation, Lahore 126
Testing effectiveness (Phase 2)Ended earlyNCT02365714
What this trial is testing

CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)

Who this might be right for
Breast CancerDCISInvasive Ductal Carcinoma
Georgetown University 2
Testing effectiveness (Phase 2)UnknownNCT03906669
What this trial is testing

A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

Who this might be right for
Early-stage Breast CancerHormone Receptor Positive Tumor
St Vincent's Hospital 200
Very early researchStudy completedNCT02802748
What this trial is testing

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 60
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Large-scale testing (Phase 3)Study completedNCT00003771
What this trial is testing

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

Who this might be right for
Breast CancerMenopausal Symptoms
Regional Oncologic Center 1,300
Large-scale testing (Phase 3)Active Not RecruitingNCT01064635
What this trial is testing

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,056
Early research (Phase 1)Not Yet RecruitingNCT07401381
What this trial is testing

Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Who this might be right for
Hormone Receptor Positive Early Breast Cancer
Rovi Pharmaceuticals Laboratories 120
Not applicableStudy completedNCT00737009
What this trial is testing

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

Who this might be right for
Breast Cancer
AstraZeneca 259
Early research (Phase 1)Looking for participantsNCT06139107
What this trial is testing

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

Who this might be right for
Breast Cancer
Mridula George, MD 15
Testing effectiveness (Phase 2)Study completedNCT05549505
What this trial is testing

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Who this might be right for
Breast Cancer
Arvinas Inc. 152
Testing effectiveness (Phase 2)Study completedNCT02273973
What this trial is testing

Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Who this might be right for
Breast Cancer
Genentech, Inc. 334